Progyny's fundamentals remain strong with solid revenue growth, impressive cash flow, and a debt-free balance sheet despite recent share price weakness.

From the company, we have Rob Davis, the company's Chairman and CEO; and Dr. Eliav Barr, who is the company's Head of Global Clinical Development and also CMO. Thank you both so much for joining us ...

Background Acute myocarditis is a potentially life-threatening cardiac condition and immediate assessment of this disease is ...